Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
OpenAI launches ChatGPT Health to connect medical records, wellness apps - 2Ariana Grande to host 'Saturday Night Live' Christmas show with Cher as musical guest, returning after nearly 40 years
- 3The Most recent Microsoft Surface Genius PC: Ideal for Very good quality Planning and Gaming Needs
- 4Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
- 5Vote in favor of Your Number one Cake Type
- Step by step instructions to Pick A Pre-owned vehicle Stage
- Russia Establishing Long-Range Drone Bases In Belarus, Warns Ukraine
- NASA set for first crewed moon return in over half a century
- New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz
- Ifo: Job cuts in Germany slowing but not enough for a turnaround
- Vote In favor of Your Favored Treat
- No injuries after blast at pro-Israel centre in the Netherlands
- African nations push to recognize crimes of colonialism in Algeria
- Africa's energy giants eye long-term gains on Iran war disruption
